✦ LIBER ✦

A phase I study of prolonged infusion 5-fluorouracil and concomitant radiation therapy in patients with squamous cell cancer of the head and neck

✍ Scribed by Burkhard Weppelmann; Ricarard H. Wheeler; Glenn E. Peters; Suzanne Stephens; Sharon A. Spencer; Ruby F. Meredith; Robert Y. Kim; Merle M. Salter

Book ID: 107964116
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 439 KB
Volume: 20
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(91)90120-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly cisplatin paclitaxel and continuo

Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

✍ M. Schena; C. Barone; N. Birocco; D. Dongiovanni; G. Numico; I. Colantonio; O. B 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 207 KB

Cisplatin and 5-fluorouracil infusion in

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

✍ Julie A. Kish; Arthur Weaver; John Jacobs; Glenn Cummings; Muhyi Al-Sarraf 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 754 KB

A phase II study of cisplatin and contin

A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer

✍ Eduardo Tellez-Bernal; Gonzalo Recondo; Thierry Guillot; Mohamed Benhamed; Chris 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

The chemotherapeutic treatment of recurrent and/or metastatic squamous cell carcinoma (SCC) of the head and neck (H & N) has a very dismal prognosis, with survival usually not exceeding 1 year. Reported objective response rates vary between 3% and 70%. This difference appears largely attributable to

A phase II study of piritrexim in patien

A phase II study of piritrexim in patients with advanced squamous head and neck cancer

✍ Wu-Ching Uen; Andrew T. Huang; Robert Mennel; Stephen E. Jones; Monica B. Spauld 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 3 views

Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the

Pilot study of intraoperative chemothera

Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck

✍ Ozlem E. Tulunay; Ileana I. Enamorado; Omer Kucuk; Lance K. Heilbrun; Jose E. Ot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 3 views

## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat

Phase I trial of combined chemotherapy w

Phase I trial of combined chemotherapy with docetaxel, cisplatin, and 5-fluorouracil for patients with locally advanced squamous cell carcinoma of the head and neck

✍ Mamoru Tsukuda; Yasukazu Mikami; Yuji Tanigaki; Hideaki Katori; Choichi Horiuchi 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 234 KB